Drug Approval | June 27, 2022
Astellas’s update on the Fortis clinical trial of AT845 in adults for pompe disease
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
63-year old woman gets rare Transcatheter Tricuspid Valve Replacement (TTVR)
Apollo Hospitals Chennai is the first healthcare institution in South India to use this protected TAVI / TAVR technology.
TLANDO was approved by the U.S. Food and Drug Administration (FDA) on March 28, 2022.
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
WHO and UNICEF call on governments, industry, donors and civil society to fund and prioritize access to assistive products
The procedures have been performed by Dr. Kaushal Pandey at P.D. Hinduja Hospital in Mumbai, India
Tembo and UFlex-Asepto have co-developed 100% renewable and recyclable paper straw solution that will be food grade, moisture-resistant and made from sustainably sourced papers
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim
The valve has a saddle-shaped sewing cuff that mimics the asymmetric shape of the native mitral valve
Subscribe To Our Newsletter & Stay Updated
